Advanced search
Publication Cover
Current Medical Research and Opinion Volume 24, 2008 - Issue 11
Submit an article Journal homepage
100
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Assessment of long-term immunological and pulmonary safety of inhaled human insulin with up to 24 months of continuous therapy

William T. Cefalu Pennington Biomedical Research Center, Baton Rouge, LA, USACorrespondence[email protected]
,
Nancy J. V. Bohannon Monteagle Medical Center, San Francisco, CA, USA
,
S. Edwin Fineberg Indiana University School of Medicine, Indianapolis, IN, USA and University of Alabama Birmingham School of Medicine, Birmingham, AL, USA
,
John G. Teeter Pfizer Global Research and Development, Groton, CT, USA
,
Pamela F. Schwartz Pfizer Global Research and Development, Groton, CT, USA
,
Joann M. Reis Pfizer Global Research and Development, Groton, CT, USA
&
Alan S. Krasner Pfizer Global Research and Development, Groton, CT, USA
 show all
Pages 3073-3083 | Accepted 20 Aug 2008, Published online: 14 Oct 2008

References

  • Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progres1sion of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86
  • UK Prospective Diabetes Study. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53
  • Hunt LM, Valenzuela MA, Pugh JA. NIDDM patients’ fears and hopes about insulin therapy: the basis of patient reluctance. Diabetes Care 1997;20:292-8
  • Koro CE, Bowlin SJ, Bourgeois N, et al. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care 2004;27:17-20
  • DeFronzo RA, Bergenstal RM, Cefalu WT, et al. Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trial. Diabetes Care 2005;28:1922-8
  • Rosenstock J, Zinman B, Murphy LJ, et al. Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial. Ann Intern Med 2005;143:549-58
  • Skyler JS, Jovanovic L, Klioze S, et al. Two-year safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 1 diabetes. Diabetes Care 2007;30:579-85
  • Hollander PA, Blonde L, Rowe R, et al. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial. Diabetes Care 2004;27:2356-62
  • Quattrin T, Belanger A, Bohannon NJ, et al. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial. Diabetes Care 2004;27:2622-7
  • Skyler JS, Weinstock RS, Raskin P, et al. Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial. Diabetes Care 2005;28:1630-5
  • Rosenstock J, Foyt H, Klioze S, et al. Inhaled human insulin (Exubera) therapy shows sustained efficacy and is well tolerated over a 2-year period in patients with type 2 diabetes (T2DM) [abstract]. Diabetes 2006;55(Suppl 1):A26
  • Fineberg SE, Kawabata T, Finco-Kent D, et al. Antibody response to inhaled insulin in patients with type 1 or type 2 diabetes: an analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trial. J Clin Endocrinol Metab 2005;90:3287-94
  • American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique – 1995 update. Am J Respir Crit Care Med 1995;152:2185-98
  • American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107-36
  • Barnett AH, Lange P, Dreyer M, et al. Long-term tolerability of inhaled human insulin (Exubera®) in patients with poorly controlled type 2 diabetes. Int J Clin Pract 2007;61:1614-25
  • Teeter JG, Riese RJ. Dissociation of lung function changes with humoral immunity during inhaled human insulin therapy. Am J Respir Crit Care Med 2006;173:1194-200
  • Skyler JS, Jovanovic L, Klioze S, et al. Two-year safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 1 diabetes. Diabetes Care 2007;30:579-85
  • Liu MC, Riese RJ, Van Gundy K, et al. Effects of inhaled human insulin on airway lining fluid composition in adults with diabetes. Eur Respir J 2008;32:180-8
  • Davis WA, Knuiman M, Kendall P, et al. Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 2004;27:752-7
  • Weynand B, Jonckheere A, Frans A, et al. Diabetes mellitus induces a thickening of the pulmonary basal lamina. Respiration 1999;66:14-19
  • Farina J, Furio V, Fernandez-Acenero MJ, et al. Nodular fibrosis of the lung in diabetes mellitus. Virchows Arch 1995;427:61-3
  • Skyler JS, for the Exubera Phase 3 Study Group. Efficacy and safety of inhaled insulin (Exubera®) compared to subcutaneous insulin therapy in an intensive insulin regimen in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial [abstract]. Diabetes 2002;55(Suppl 2):A134

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.